Headlines:
Tag: Clinical
Panaxia Announces Positive Top-Line Results From Its Clinical Trial In Leading Medical Cannabis Products

Panaxia Announces Positive Top-Line Results From Its Clinical Trial In Leading Medical Cannabis Products

December 18, 2019 Economie

Results demonstrate efficacy of absorption in the blood and safety of tablets, suppositories and inhaled cannabis extract In addition, data show that Panaxia's sublingual ...

Lees verder
Adagio Medical Announces First Patient Enrollment in its iCLAS(TM) U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Pers

Adagio Medical Announces First Patient Enrollment in its iCLAS(TM) U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Pers

December 17, 2019 Economie

LAGUNA HILLS, California, Dec. 17, 2019 /PRNewswire/ -- Adagio Medical, Inc. (Adagio) today announced it has enrolled the first patient in its iCLAS(TM) Investigational Device ...

Lees verder
Clinical Results from the MolecuLight i:X® Fluorescence Imaging System are Featured in Two Clinical Talks and Seven Posters at the SAWC Fall 2019

Clinical Results from the MolecuLight i:X® Fluorescence Imaging System are Featured in Two Clinical Talks and Seven Posters at the SAWC Fall 2019

October 13, 2019 Economie

Multiple Trials Illustrate the Significant Clinical Benefit of MolecuLight's Point-of-Care Fluorescence Imaging Device for Chronic Wound Management LAS VEGAS, Nevada and ...

Lees verder
Results from Clinical Studies using MolecuLight i:X® Fluorescence Imaging System Featured Prominently at the Wounds Canada 2019 Annual Conference

Results from Clinical Studies using MolecuLight i:X® Fluorescence Imaging System Featured Prominently at the Wounds Canada 2019 Annual Conference

October 4, 2019 Economie

Point-of-Care Fluorescence Imaging for Chronic Wounds and its Significant Clinical Benefits are Featured at the Largest Canadian Wound Care Conference in 5 Clinical Talks and ...

Lees verder
Pharming Announces Initiation of Clinical Phase I/II Pre-Eclampsia Study

Pharming Announces Initiation of Clinical Phase I/II Pre-Eclampsia Study

June 11, 2019 Economie

LEIDEN, Netherlands, June 11, 2019 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") today announces that, following receipt of the Dutch investigating ...

Lees verder
Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with

Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with

June 3, 2019 Economie

ASCO Abstract # Tepotinib (MET kinase inhibitor): 9005 Not intended for UK- , Canada- or US-based media DARMSTADT, Germany, June 3, 2019 /PRNewswire/ -- -- ...

Lees verder
Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton´s Tyrosine Kinase (BTK) Inhibitor to Repor

Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton´s Tyrosine Kinase (BTK) Inhibitor to Repor

May 11, 2019 Economie

Not intended for U.S. media -- 48-week results provide additional evidence of relapse reduction for investigational evobrutinib -- Evobrutinib demonstrated ...

Lees verder
Medasense Announces Positive Results From Clinical Outcome Studies Using the NOL® Monitoring Technology for Optimized Pain Control

Medasense Announces Positive Results From Clinical Outcome Studies Using the NOL® Monitoring Technology for Optimized Pain Control

October 31, 2018 Economie

RAMAT GAN, Israel, October 31, 2018 /PRNewswire/ -- The leading study, investigating NOL-guided opioid administration, demonstrated that using the NOL technology significantly ...

Lees verder
Johnson & Johnson Vision Showcases Latest Clinical Data and Eye Care Solutions at the ESCRS 2018 Annual Meeting

Johnson & Johnson Vision Showcases Latest Clinical Data and Eye Care Solutions at the ESCRS 2018 Annual Meeting

September 21, 2018 Economie

- Latest clinical data builds on the wealth of evidence supporting the safety, efficacy and overall benefits of TECNIS Symfony® IOLs for cataract patients - Showcasing one of ...

Lees verder
AAIC® 2018 Features First Clinical Trial to Show Intensive Blood Pressure Treatment Reduces New Cases of Mild Cognitive Impairment and Dementia (

AAIC® 2018 Features First Clinical Trial to Show Intensive Blood Pressure Treatment Reduces New Cases of Mild Cognitive Impairment and Dementia (

July 29, 2018 Economie

CONFERENCE ALSO RELEASES FIRST-EVER DEMENTIA DATA IN LGB SENIORS, AND WOMEN'S DEMENTIA RISK RELATED TO REPRODUCTIVE HISTORY CHICAGO, July 25, 2018 /PRNewswire/ -- The first ...

Lees verder
Nieuwe berichten
BizPress.nl